Delivery Order SPE2DB20D6037-SPE2DB25FTVW4

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,265.60 contract is for the delivery of 4565110642 - LIDOCAINE 5% PATCH 30S, with a completion date of July 11, 2024. DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through December 31,...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,914.30 contract was issued by the Defense Logistics Agency (DLA) on November 10, 2022, with a completion date of November 14, 2022. The contract is for the delivery of a pharmaceutical product, specifically 4559060398 ! LIDOCAINE 5% PATCH 30S, with no set-aside designation. DMS Pharmaceutical Group holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,827.00 firm fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S to military health facilities. The order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the DLA to issue delivery...
This federal contract award, valued at $1,961.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4560677400 - LIDOCAINE 5% PATCH 30S, with a completion date of April 24, 2023. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4559549119 - Lidocaine 5% Patch 30s. The delivery order has a ceiling value of $2,540.42 and an ultimate completion date of January 11, 2023. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a wide range of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,030.72 contract is for the supply of 4562532790 - LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued up to $499,999,999 and running through December 31, 2025. This single-award IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,796.80 contract is for the supply of 4562162772 - Lidocaine 5% Patch 30s, with a completion date of Sep 14, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,623.81 contract is for the delivery of Lidocaine 5% Patches. It is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the issuance of delivery orders for a comprehensive range of...
This is a $7,593.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of 4,563,767,512 units of Lidocaine 5% Patch 30s, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,064.32 contract is for the delivery of Lidocaine 5% Patches to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB25FTVW4
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a prescription medication, with a ceiling value of $1,181.52 and a period of performance through June 13, 2025.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Generated 9/11/25, 10:54 AM